Showing results (1661-1670 of 2,429) with videos related to
Sort By:
Pageof 243
Frontiers in Neurology|October 19, 2018
Outcome Measures for Central Nervous System Evaluation in Myotonic Dystrophy Type 1 May Be Confounded by Deficits in Motor Function or InsightMark J Hamilton, John McLean, Sarah Cumming, et al.The Journal of Hospital Infection|October 13, 2009
Performance of ultramicrofibre cleaning technology with or without addition of a novel copper-based biocideD Hamilton, A Foster, L Ballantyne, et al.JAMA Cardiology|January 14, 2026
Prediabetes, Subclinical Myocardial Injury or Stress, and Heart Failure Risk for Adults With HypertensionArnaud D Kaze, Stephen P Juraschek, Jordana B Cohen, et al.Gerontology|July 24, 2024
Anemia, Iron Deficiency, and Cause-Specific Mortality: The Atherosclerosis Risk in Communities StudyEthan J Cannon, Jeffrey R Misialek, Leo F Buckley, et al.Journal of the American Society for Mass Spectrometry|December 4, 2025
Development of Low-Flow High-Resolution Desorption Electrospray Ionization Mass Spectrometry ImagingMark W Towers, Rachel J DeHoog, Trevor M Godfrey, et al.Innovation in Aging|November 24, 2025
Age-related variations in HbA1c improvements: insights from a telehealth-supported community-based interventionLaura Porterfield, Xiaoying Yu, Amber B Amspoker, et al.The American Journal of Cardiology|August 1, 1997
Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS])J A Herd, C M Ballantyne, J A Farmer, et al.Circulation|September 24, 2024
NT-proBNP and Cardiac Troponin I, but Not Cardiac Troponin T, Are Associated With 7-Year Changes in Cardiac Structure and Function in Older Adults: The ARIC StudyPeder L Myhre, Brian Claggett, Christie M Ballantyne, et al.Diabetes, Obesity & Metabolism|August 4, 2004
Characteristics of US adults with the metabolic syndrome and therapeutic implicationsT A Jacobson, C C Case, S Roberts, et al.The American Journal of Cardiology|April 28, 2022
Long-Term Safety and Efficacy of Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from the CLEAR Harmony Open-Label Extension Study)Christie M Ballantyne, Maciej Banach, Harold E Bays, et al.Pageof 243